NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
04 October 2024
| Name: | THE HYDRATION PHARMACEUTICALS COMPANY LIMITED (HPC) |
| ISIN: | AU0000187957 |
| Date of Listing: | 29 December 2021 |
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
This is a current registered entity, not in any form of external administration to our knowledge.Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of The Hydration Pharmaceuticals Company Limited will be lifted immediately following the release by HPC of an announcement regarding a placement and entitlement offer capital raising. | 03/08/2023 |
The company releases a notice of proposed issue of securities. | 03/08/2023 |
The company releases its Capital Raise Investor Presentation. | 03/08/2023 |
Firm commitments to raise $1.5m at an offer price of $0.045 per share under an institutional placement. Additional 1 for 2.27 pro rata, partially underwritten, non-renounceable entitlement offer to raise up to approximately $3.3m at the Offer Price. Entitlement offer partially underwritten by BW Equities Pty Ltd for up to approximately $2.5 million. New shares will be offered with one attaching option for every two new shares issued, exercisable at $0.07 on or before 31 December 2025. In addition, PURE Asset Management to exercise approximately $0.4m worth of Warrants associated with the first tranche of its senior secured debt taking total new funding to up to ~$5.2m. Funds to be deployed towards strategic marketing and product development initiatives designed to drive revenue growth over coming quarters. Capital raise follows recent operational success and execution of strategy to reduce expenditure while maintaining consistent top-line revenue growth. | 03/08/2023 |
The securities of The Hydration Pharmaceuticals Company Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HPC, pending the release of an announcement regarding a capital raising. | 02/08/2023 |
listed entity carried for record purposes only | 29/12/2021 |
The suspension of trading in the securities of The Hydration Pharmaceuticals Company Limited will be lifted immediately following the release by HPC of an announcement regarding a placement and entitlement offer capital raising. | 03/08/2023 |
The company releases a notice of proposed issue of securities. | 03/08/2023 |
The company releases its Capital Raise Investor Presentation. | 03/08/2023 |
Firm commitments to raise $1.5m at an offer price of $0.045 per share under an institutional placement. Additional 1 for 2.27 pro rata, partially underwritten, non-renounceable entitlement offer to raise up to approximately $3.3m at the Offer Price. Entitlement offer partially underwritten by BW Equities Pty Ltd for up to approximately $2.5 million. New shares will be offered with one attaching option for every two new shares issued, exercisable at $0.07 on or before 31 December 2025. In addition, PURE Asset Management to exercise approximately $0.4m worth of Warrants associated with the first tranche of its senior secured debt taking total new funding to up to ~$5.2m. Funds to be deployed towards strategic marketing and product development initiatives designed to drive revenue growth over coming quarters. Capital raise follows recent operational success and execution of strategy to reduce expenditure while maintaining consistent top-line revenue growth. | 03/08/2023 |
The securities of The Hydration Pharmaceuticals Company Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HPC, pending the release of an announcement regarding a capital raising. | 02/08/2023 |
listed entity carried for record purposes only | 29/12/2021 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 31/05/2023 | George Livery | 50,000 | $0.060 | $3,000 |
| 24/03/2023 | George Livery | 69,104 | $0.069 | $4,768 |
| 07/03/2023 | Margaret Hardin | 39,130 | $0.069 | $2,700 |
| 23/12/2022 | George Livery | 50,000 | $0.099 | $4,950 |
| 29/06/2022 | George Livery | 50,000 | $0.125 | $6,250 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Adem Karafili | Non Exec Chairman | 15/10/2018 |
| Oliver Baker | Managing Director, CEO | 13/12/2021 |
| Chris Kavanaugh | CFO | 13/12/2021 |
| Margaret Hardin | Independent Director | 08/02/2022 |
| Nick Berry | Non Exec Director | 25/05/2024 |
| Victoria Nadalin | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| George Livery | Non Exec Chairman, Independent Director | 02/11/2021 | 25/05/2024 |
| Gretta van Riel | Independent Director | 02/11/2021 | 26/09/2023 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
